174 related articles for article (PubMed ID: 33154241)
21. Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil.
Bail L; Ito CAS; Arend LNVS; Pilonetto M; Nogueira KDS; Tuon FF
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115239. PubMed ID: 33130509
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions.
Castanheira M; Davis AP; Serio AW; Krause KM; Mendes RE
Diagn Microbiol Infect Dis; 2019 May; 94(1):73-77. PubMed ID: 30661726
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Acinetobacter baumannii clinical isolates carrying bla(OXA-23) carbapenemase and 16S rRNA methylase armA genes in Yemen.
Bakour S; Alsharapy SA; Touati A; Rolain JM
Microb Drug Resist; 2014 Dec; 20(6):604-9. PubMed ID: 24901296
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
Juhas M; Widlake E; Teo J; Huseby DL; Tyrrell JM; Polikanov YS; Ercan O; Petersson A; Cao S; Aboklaish AF; Rominski A; Crich D; Böttger EC; Walsh TR; Hughes D; Hobbie SN
J Antimicrob Chemother; 2019 Apr; 74(4):944-952. PubMed ID: 30629184
[TBL] [Abstract][Full Text] [Related]
25. Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates.
Costello SE; Deshpande LM; Davis AP; Mendes RE; Castanheira M
J Glob Antimicrob Resist; 2019 Mar; 16():278-285. PubMed ID: 30389638
[TBL] [Abstract][Full Text] [Related]
26. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
27. Aminoglycoside resistance determinants in multiresistant
Cirit OS; Fernández-Martínez M; Yayla B; Martínez-Martínez L
Acta Microbiol Immunol Hung; 2019 Sep; 66(3):327-335. PubMed ID: 30803254
[No Abstract] [Full Text] [Related]
28. Genetic analysis of carbapenemase-producing Gram-negative bacteria isolated from a university teaching hospital in Egypt.
Soliman AM; Zarad HO; Nariya H; Shimamoto T; Shimamoto T
Infect Genet Evol; 2020 Jan; 77():104065. PubMed ID: 31634643
[TBL] [Abstract][Full Text] [Related]
29. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH
Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487
[TBL] [Abstract][Full Text] [Related]
30. Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes.
Cox G; Ejim L; Stogios PJ; Koteva K; Bordeleau E; Evdokimova E; Sieron AO; Savchenko A; Serio AW; Krause KM; Wright GD
ACS Infect Dis; 2018 Jun; 4(6):980-987. PubMed ID: 29634241
[TBL] [Abstract][Full Text] [Related]
31. OXA-181-Like Carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from Septicemic Neonates: Coexistence with NDM-5, Resistome, Transmissibility, and Genome Diversity.
Naha S; Sands K; Mukherjee S; Saha B; Dutta S; Basu S
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441403
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
[TBL] [Abstract][Full Text] [Related]
33. Dissemination of genetically diverse NDM-1, -5, -7 producing-Gram-negative pathogens isolated from pediatric patients in Pakistan.
Qamar MU; Walsh TR; Toleman MA; Tyrrell JM; Saleem S; Aboklaish A; Jahan S
Future Microbiol; 2019 May; 14():691-704. PubMed ID: 31148474
[No Abstract] [Full Text] [Related]
34. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals.
Yan JJ; Wu JJ; Ko WC; Tsai SH; Chuang CL; Wu HM; Lu YJ; Li JD
J Antimicrob Chemother; 2004 Dec; 54(6):1007-12. PubMed ID: 15486082
[TBL] [Abstract][Full Text] [Related]
35. Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos U; Silva-Sánchez J; López-Jácome LE; Hernández-Durán M; Colín-Castro CA; Sánchez-Pérez A; Rodríguez-Santiago J; Morfín-Otero R; Rodriguez-Noriega E; Velázquez-Acosta MD; Vázquez-Larios MDR; Feliciano-Guzmán JM; Rojas-Larios F; Ponce-De-Leon A; Lozano-Garcia M; Choy-Chang EV; López-Gutiérrez E; Molina-Jaimes A; Gil-Veloz M; Corte-Rojas RE; López-Ovilla I; Ramirez-Mis JL; Rodríguez-Balderas DE; Molina-Chavarria A; Padilla-Ibarra C; Quevedo-Ramos MA; Mireles-Dávalos CD; Rodríguez-Medina N; Rubio-Mendoza D; Córdova-Fletes C; Cruz-López F; Becerra-Montejano DA; Mercado-Longoria R; Martínez-Villarreal RT; Barlandas-Rendón NRE; Mena-Ramírez JP; Couoh-May CA; Alcaraz-Espejel M; Adame-Alvarez C; Hernández-Vicente L; Garza-González E
Microb Drug Resist; 2023 Jun; 29(6):239-248. PubMed ID: 36595348
[TBL] [Abstract][Full Text] [Related]
36. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
Founou RC; Founou LL; Allam M; Ismail A; Essack SY
Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
38. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae.
Thwaites M; Hall D; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866876
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of plazomicin MICs obtained using agar dilution versus broth microdilution methods and impact of inoculum size against ESBL-producing Escherichia coli, carbapenemase-producing Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus clinical isolates.
Emiliov T; Rodríguez-Avial I; López-Diaz MDC; Culebras E
Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114867. PubMed ID: 31402069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
